Dr Dan WengÂ
Chief Executive Officer
Finance
Ergomed
India
Biography
"Dr Weng joined Ergomed as CEO in July 2017 after six years at EPS International Holding Co., where he was Chairman, President and CEO. He was also a Board Director of EPS Holdings, Inc., a global CRO listed on the Tokyo Stock Exchange Prior to this, Dan delivered growth in executive positions at international CROs including MedPace, Icon Clinical Research, PharmaNet and Quintiles, for over 20 years. His background covers multiple therapeutic areas, supporting all stages of development through to approval."
Research Interest
Clinical Development
